Biotech company enGene to go public in Forbion-sponsored SPAC merger
Upon closing of the deal, the combined company will be named enGene Holdings, whose common shares are expected to be listed on the Nasdaq.
17 May 2023•2 mins read
Upon closing of the deal, the combined company will be named enGene Holdings, whose common shares are expected to be listed on the Nasdaq.
